Federica Sodano

Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Retraction notice to "FS536, a novel nitric oxide-releasing doxorubicin hybrid, reverts multidrug resistance in lung cancer cells" [Journal of Controlled Release 382 (2025) 113732].

Retraction notice to "FS536, a novel nitric oxide-releasing doxorubicin hybrid, reverts multidrug resistance in lung cancer cells" [Journal of Controlled Release 382 (2025) 113732].

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: May 09, 2026

Exploring a Ugi-Mediated Polymerization-Induced Self-Assembly Approach to Peptoid Particles.

Exploring a Ugi-Mediated Polymerization-Induced Self-Assembly Approach to Peptoid Particles.

Journal: Macromolecular rapid communications

Published: February 20, 2026

A resveratrol-hydrogen sulfide donor hybrid as a multi-target therapeutic strategy for allergic asthma.

A resveratrol-hydrogen sulfide donor hybrid as a multi-target therapeutic strategy for allergic asthma.

Journal: Pharmacological research

Published: December 19, 2025

Lipo-Glc-1,6-P2: A Bioprecursor Prodrug for Phosphomannomutase-2 Congenital Disorder of Glycosylation.

Lipo-Glc-1,6-P2: A Bioprecursor Prodrug for Phosphomannomutase-2 Congenital Disorder of Glycosylation.

Journal: IUBMB life

Published: July 10, 2025

Quantitative analysis of pesticide residues in wine grapes during a downy mildew infestation using LC-MS/MS and associated risk assessment.

Quantitative analysis of pesticide residues in wine grapes during a downy mildew infestation using LC-MS/MS and associated risk assessment.

Journal: Food chemistry

Published: April 23, 2025

Light-Activatable Hyaluronic Acid-Derivatives Releasing Nitric Oxide and Their Delivery in the Skin.

Light-Activatable Hyaluronic Acid-Derivatives Releasing Nitric Oxide and Their Delivery in the Skin.

Journal: Advanced healthcare materials

Published: February 03, 2025

FS536, a novel nitric oxide-releasing doxorubicin hybrid, reverts multidrug resistance in lung cancer cells.

FS536, a novel nitric oxide-releasing doxorubicin hybrid, reverts multidrug resistance in lung cancer cells.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: January 14, 2025

Synthesis of Arginase Inhibitors: An Overview.

Synthesis of Arginase Inhibitors: An Overview.

Journal: Pharmaceutics

Published: December 17, 2024

Opportunities and Challenges of Arginase Inhibitors in Cancer: A Medicinal Chemistry Perspective.

Opportunities and Challenges of Arginase Inhibitors in Cancer: A Medicinal Chemistry Perspective.

Journal: Journal of medicinal chemistry

Published: November 19, 2024

Eco-friendly Synthesis and Molecular Modelling of 2-Phenylimidazo[1,2-b]pyridazine Derivatives: In Vitro and In Vivo Studies for Lead Optimization.

Eco-friendly Synthesis and Molecular Modelling of 2-Phenylimidazo[1,2-b]pyridazine Derivatives: In Vitro and In Vivo Studies for Lead Optimization.

Journal: ChemMedChem

Published: September 12, 2024

A new biocompatible butyric acid-releasing glucosamine derivative for transdermal delivery.

A new biocompatible butyric acid-releasing glucosamine derivative for transdermal delivery.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: July 15, 2024

Isothiocyanate-Corticosteroid Conjugates against asthma: Unity makes strength.

Isothiocyanate-Corticosteroid Conjugates against asthma: Unity makes strength.

Journal: European journal of medicinal chemistry

Published: May 27, 2024

Showing 1-12 of 41

Last Updated: 09/26/2026